We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

UPXI:NASDAQUpexi, Inc. Analysis

Data as of 2026-06-20 - not real-time

$0.91

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Upexi, Inc. (UPXI) is trading at $0.91, well below its 20‑day SMA of 1.06 and 50‑day SMA of 1.23, indicating a pronounced bearish price bias. The RSI of 38 suggests limited upside momentum, while the MACD histogram is negative, reinforcing a bearish technical stance. Volatility is extreme at nearly 97% over the past 30 days and the computed beta of 4.26 points to outsized market swings.
Fundamentally, the company reports a 44% revenue growth year‑over‑year, yet operating margins are a disastrous -23.4% and EBITDA is deeply negative. Cash reserves of only $3.5 M are dwarfed by debt exceeding $242 M, and free cash flow is a massive negative, while book value per share sits at -$0.78. The PE ratio of 1.7 looks cheap against an industry average of 16.6, but earnings are essentially zero and forward PE is negative, making valuation metrics misleading. Combined with high regulatory exposure in cannabis and crypto, the stock presents a high‑risk profile despite a theoretical upside of over 450%.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Price below all major moving averages and bearish MACD
  • Extreme short‑term volatility and beta
  • Negative operating cash flow and free cash flow

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Revenue growth of 44% suggests top‑line potential
  • Continued negative margins and high debt constrain profitability
  • Potential catalyst if restructuring or new product lines improve cash generation

Long Term

> 3 years
Cautious
Model confidence: 6/10

Key Factors

  • Sustained negative earnings and zero ROE
  • Heavy debt load relative to cash and market cap
  • Regulatory headwinds in cannabis, crypto and supplement categories

Key Metrics & Analysis

Financial Health

Revenue Growth44.20%
P/E Ratio1.7
ROA-126.53%
P/B Ratio-1.2
Op. Cash Flow$-21524226
Free Cash Flow$-229092160
Industry P/E16.7

Technical Analysis

TrendBearish
RSI38.1
Support$0.85
Resistance$1.42
MA 20$1.06
MA 50$1.23
MA 200$2.55
MACDBearish
VolumeStable
Fear & Greed Index91.46

Valuation

Target Price$5.00
Upside/Downside450.90%
GradeOvervalued
TypeValue

Risk Assessment

Beta4.26
Volatility97.36%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.